Edosada Conrad Yap, Quan Clifford, Tran Thuy, Pham Victoria, Wiesmann Christian, Fairbrother Wayne, Wolf Beni B
Department of Molecular Oncology, Genentech, Inc., 1 DNA Way - MS42, South San Francisco, CA 94080, USA.
FEBS Lett. 2006 Mar 6;580(6):1581-6. doi: 10.1016/j.febslet.2006.01.087. Epub 2006 Feb 3.
Fibroblast activation protein (FAP) is a serine protease of undefined endopeptidase specificity implicated in tumorigenesis. To characterize FAP's P(4)-P(2)(') specificity, we synthesized intramolecularly quenched fluorescent substrate sets based on the FAP cleavage site in alpha(2)-antiplasmin (TSGP-NQ). FAP required substrates with Pro at P(1) and Gly or d-amino acids at P(2) and preferred small, uncharged amino acids at P(3), but tolerated most amino acids at P(4), P(1)(') and P(2)('). These substrate preferences allowed design of peptidyl-chloromethyl ketones that inhibited FAP, but not the related protease, dipeptidyl peptidase-4. Thus, FAP is a narrow specificity endopeptidase and this can be exploited for inhibitor design.
成纤维细胞活化蛋白(FAP)是一种丝氨酸蛋白酶,其内切肽酶特异性尚不明确,与肿瘤发生有关。为了表征FAP的P(4)-P(2)'特异性,我们基于α(2)-抗纤溶酶中的FAP切割位点合成了分子内淬灭荧光底物组(TSGP-NQ)。FAP需要P(1)位为Pro、P(2)位为Gly或d-氨基酸的底物,并且P(3)位偏好小的、不带电荷的氨基酸,但对P(4)、P(1)'和P(2)'位的大多数氨基酸都能耐受。这些底物偏好使得能够设计出抑制FAP但不抑制相关蛋白酶二肽基肽酶-4的肽基氯甲基酮。因此,FAP是一种特异性较窄的内切肽酶,这可用于抑制剂设计。